Skip to main content
Fig. 7 | BMC Complementary Medicine and Therapies

Fig. 7

From: Shikonin reactivates TSGs GADD45B and PPP3CC to block NSCLC cell proliferation and migration through JNK/P38/MAPK signaling pathways

Fig. 7

TSGs GADD45 B and PPP3CC are correlated with patient prognosis in clinic. A-B. GADD45B and PPP3CC expression was positively correlated with patient survival outcomes by Kaplan–Meier plots. C. The schematic diagram of the present study. Shikonin treatment activates the expression of GADD45B and PPP3CC through the JNK/P38/MAPK pathway, thus inhibiting the growth and migration of NSCLC cells

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us